RespireRx Pharmaceuticals Inc.
RSPI · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $0 | $1 | $1 | $17 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $23 | $207 | $84 | $29 |
| Total Curr. Assets | $23 | $209 | $85 | $45 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $178 | $53 | $0 |
| Total NC Assets | $0 | $178 | $53 | $0 |
| Other Assets | $0 | -$178 | -$53 | $0 |
| Total Assets | $23 | $209 | $85 | $45 |
| Liabilities | – | – | – | – |
| Payables | $5,724 | $5,236 | $4,924 | $3,772 |
| Short-Term Debt | $2,709 | $2,078 | $1,684 | $1,634 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $230 | $0 | -$3 |
| Other Curr. Liab. | $3,296 | $2,378 | $1,541 | $2,087 |
| Total Curr. Liab. | $11,729 | $9,922 | $8,148 | $7,490 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $174 | $294 | $0 | $0 |
| Total NC Liab. | $174 | $294 | $0 | $1,634 |
| Other Liabilities | $0 | $0 | -$1,684 | -$1,634 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $11,903 | $10,216 | $8,148 | $7,490 |
| Equity | – | – | – | – |
| Pref Stock | $22 | $22 | $22 | $22 |
| Common Stock | $126 | $98 | $71 | $4 |
| Retained Earnings | -$176,058 | -$173,955 | -$170,810 | -$166,509 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $164,030 | $163,828 | $162,654 | $159,042 |
| Total Equity | -$11,880 | -$10,008 | -$8,063 | -$7,445 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $23 | $209 | $85 | $45 |
| Net Debt | $2,709 | $2,077 | $1,683 | $1,618 |